Nicotine in Neurodegenerative and Neuropsychiatric Disorders: Mechanisms and Clinical Evidence
This review critically examines the current state of preclinical and clinical evidence on nicotine’s addictive potential, receptor subtype activity, cognitive and emotional modulation, and human trial data, and highlights both the promise and challenges of developing nicotinic-based therapeutics for brain disorders.